NASDAQ: AKTS
Aktis Oncology Inc Earnings Dates, Reports, Calls

Aktis Oncology earnings were N/A for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest AKTS earnings report on Sep 30, 2025 announced Q3 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AKTS reported annual earnings of -$44.0M, with 53.6% growth.

AKTS earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

AKTS Return on Equity

Insufficient data to display

AKTS Return on Assets

Insufficient data to display

Be the first to know when AKTS announces earnings.

AKTS Return on Capital Employed

Current Company
0%
Current Industry
-3.5%

AKTS vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AAPGN/A-$161.45MN/A-$2.02
AARD-$48.34M-$48.77MN/A-$4.30
ABVXN/AN/AN/AN/A
ABUS-$41.48M-$42.28MN/A-$0.23
ABVC-$3.58M-$4.12MN/A-$0.20

Aktis Oncology Earnings Reports & History FAQ

What was AKTS's earnings growth in the past year?

As of Aktis Oncology's earnings date in Q1 2026, Aktis Oncology's earnings has grown year over year. AKTS earnings in the past year totalled N/A.

If you're new to stock investing, here's how to buy Aktis Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.